Werewolf Therapeutics, Inc.
HOWL
$0.86
-$0.06-6.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.84M | -73.14M | -72.41M | -70.52M | -62.12M |
| Total Depreciation and Amortization | 1.68M | 1.73M | 1.78M | 1.81M | 1.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 9.61M | 10.19M | 9.73M | 9.99M | 9.66M |
| Change in Net Operating Assets | -1.97M | 405.00K | 1.07M | 2.53M | 4.11M |
| Cash from Operations | -63.52M | -60.83M | -59.84M | -56.19M | -46.52M |
| Capital Expenditure | -123.00K | -126.00K | -143.00K | -254.00K | -329.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -123.00K | -126.00K | -143.00K | -254.00K | -329.00K |
| Total Debt Issued | 0.00 | 0.00 | 30.00M | 30.00M | 30.00M |
| Total Debt Repaid | 0.00 | 0.00 | -40.00M | -40.00M | -40.00M |
| Issuance of Common Stock | 6.21M | 2.94M | 3.50M | 23.76M | 30.29M |
| Repurchase of Common Stock | -- | -6.00K | -6.00K | -6.00K | -6.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -673.00K | -673.00K | -673.00K |
| Cash from Financing | 6.21M | 2.93M | -7.18M | 13.08M | 19.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.43M | -58.02M | -67.16M | -43.36M | -27.24M |